SLIDE 1 Developing and applying stroke systems of care
Andrew M. Demchuk MD FRCPC Director, Calgary Stroke Program Deputy Department Head, Dept Clinical Neurosciences HSF Chair in Stroke Research Professor, Depts of Clinical Neurosciences and Radiology Cumming School of Medicine University of Calgary
SLIDE 2 Disclosure Slide
- I have not received an honorarium from Hoffman LaRoche
(licensure of tPA) but have received honorarium from Medtronic (supplier of SOLITAIRE FR stentriever) for CME events
- No stocks or direct investments with pharmaceutical or device
companies involved in stroke
- Co-founder/shareholder Quikflo Health start-up (acute stroke
software)
- Several clinical trial responsibilities:
- IMS-3- Exec committee, CT core lab PI
- ESCAPE- Neuro-PI
- REVASCAT- CT core lab co-PI
- CLOTBUST-ER – CTA substudy PI
- ARTSS-2 – CTA substudy core lab PI
- ENCHANTED – International Advisory Committee
- PRACTICE- DMC chair
- DEFUSE 3- Safety monitor
- ANNEXA-4 – Adjudication committee
SLIDE 3 3
Stroke Care Continuum
Stroke Onset EMS Transport ED Time Stroke Team Assessment Imaging Acute Treatment Admission
Clinical Worsening/ Complication Prevention
Rehabilitation Reintegration Secondary Prevention Primary Prevention
SLIDE 4 Treatments for Complication Prevention
Stroke units ASA
CT scan Hemicraniectomy
1970 1980 1990 1995 2000 2002 2004 2010 2013 2015
Above knee pneumatic compression stockings Early enteral feeding good
No Early BP lowering
SLIDE 5 Per million population
SLIDE 6
SLIDE 7 Reperfusion Treatment Advances
tPA<3h
CT scan tPA 3-4.5h tPA for elderly
1970 1980 1990 1995 2000 2002 2004 2008 2011 2013 2015
Endovascular tx
Thrombectomy
SLIDE 8 Two Decades Behind But Finally an Impactful Treatment
2016 1976
2016
Goyal et al Mechanical Thrombectomy***
SLIDE 9
Intravenous rtPA Balance between benefit and risk
SLIDE 10 Large clot Proximal artery Severe deficits
10
SLIDE 11 SolitaireTM FR TREVO
Thrombectomy: Stent retrieval devices
Thrombus in the stent and aspirate
SLIDE 12 10 20 30 40 50 60 70 80 90
Series 3
Series 3
TICI 2b- 3
Stent Retrieval Devices: High Reperfusion Rates
Stroke 2004 1 ; Stroke 2007 2; NEJM 2013 3,4; Lancet 2012 5; Lancet 20126 ; ISC 20127 ; Stroke 20128; ISC 20139
SLIDE 13
SLIDE 14 14 Independence Dependence
SLIDE 16 Shifting the Paradigm in Alberta
Stroke Care in the 21st Century
ESCAPE Inclusion criteria
stroke (NIHSS > 5)
- 12 hour window
- No upper age limit
- Good functional
status
16
SLIDE 17 The 3-5 minute CT/CTA protocol
EIC- ASPECTS Small core >6 Occlusion site M1+/-ICA “Collaterals” good/mod
17
SLIDE 18 Overall Results
2016-03-21 www.escapetrial.org 18
29.3% 53.0%
RR: 1.8 (1.4-2.4) NNT = 4.2 [1/0.237]
SLIDE 19 Overall Results
19
cOR: 2.6 (1.7-3.8) NNT ~3
SLIDE 20 Safety Outcomes
20
Intervention [n=165] Control
[n=150]
RR (CI95) Adjusted§ RR (CI95)
Death [N=311] 10.4% 19.0% 0.5 (0.3-0.95) 0.5 (0.3-0.8) Large/malignant MCA stroke 4.9% 10.7% 0.5 (0.2-1.0) 0.3 (0.1-0.7) sICH (clinically determined
at site)
3.6% 2.7% 1.4 (0.4-4.7) 1.2 (0.3-4.6) Access site hematoma 1.8% 0%
0.6% 0%
SLIDE 21 Endovascular thrombectomy after large-vessel ischemic stroke: a meta-analysis of individual patient data from five randomised trials HERMES Collaborators
Highly Effective Reperfusion evaluated in Multiple Endovascular Stroke trials (HERMES)
2016-03-21 HERMES Collaboration 21
SLIDE 22 Overall Treatment Effect
2016-03-21 HERMES Collaboration 22
SLIDE 23 Overall Treatment Effect NNT = 2.6
2016-03-21 HERMES Collaboration 23
25.5% 46%
SLIDE 24 Benefit even if not tPA eligible
2016-03-21 HERMES Collaboration 24
SLIDE 25 Patients much improved the next day
2016-03-21 HERMES Collaboration 25
SLIDE 26 No increased bleeding Reduction in Mortality trend
2016-03-21 HERMES Collaboration 26
SLIDE 27 Treatment effect by age mRS 0-2 at 90 days
2016-03-21 HERMES Collaboration 27
SLIDE 28 Effect size by NIHSS
2016-03-21 HERMES Collaboration 28
SLIDE 29 Treatment effect is strongest if carotid occlusion (pint=0.17)
2016-03-21 HERMES Collaboration
SLIDE 30 Treatment effect is strong if cervical ICA too (pint=0.17)
2016-03-21 HERMES Collaboration
SLIDE 31 Onset to Substantial Reperfusion and Disability Outcomes (mRS) at 3 Months
2016-03-21 HERMES Collaboration 31
SLIDE 32 Onset to Randomization and Disability Outcomes (mRS) at 3 Months
2016-03-21 HERMES Collaboration 32
3-5% absolute decrease in good outcome per hour 1-2% absolute increase in mortality per hour
SLIDE 33
~1 in 4 or 5 strokes = EVT accessible occlusion 100-150 endo eligible/1 million/yr
What is the potential for EVT?
SLIDE 34 During this Morning Somewhere in Western Canada…. At least one individual has suffered a major ischemic stroke that is very suitable for endovascular rescue if….
SLIDE 35
Endovascular Treatment How Do We Build The System of Care To Do This?
SLIDE 36
~40 PCI Facilities in Canada
for Acute Myocardial Infarction
SLIDE 37
Is Your Region Equipped with Stroke Thrombectomy Facilities Nearby?
Are there neurointerventionalists available 24h/365d at these facilities?
SLIDE 38 The How To?
- EMS transport to right hospital
SLIDE 39 How are ambulances routing hyperacute major deficit patients?
PSC CSC PSC PSC EMS transport to any hospital should be unacceptable!
SLIDE 40 Centralize care: Redirect ambulance to stroke centre
PSC CSC PSC PSC
SLIDE 41
US Model of Hubs and Spoke Model
SLIDE 42 42
“Time is Brain”
Primary Stroke Centre (PSC) Criteria: CT scan availability Door to CT time less than 20 minutes with pre-alert Stroke expertise on-site or available by Telestroke link rtPA treatment availability Serves all surrounding communities in which it is the nearest PSC Comprehensive Stroke Centre (CSC) Criteria: CT scan availability Door to CT time less than 20 minutes with pre-alert Stroke team on-site Neurosurgical expertise on-site Neuro-interventionist expertise on-site Central hub of stroke neurologist expertise in a telestroke network
Stroke Centre Designation Criteria
SLIDE 43 43
Alberta Acute Stroke Treatment 2016
Comprehensive Stroke Centre Primary Stroke Centre
SLIDE 44
SLIDE 45
Transport decisions evolving
SLIDE 46 Transport decisions evolving
angio EVT
SLIDE 47 The How To?
- EMS transport to right hospital
- Primary Stroke Centres
- CT/CTA 24/7
- Telestroke capability to hub CSC
SLIDE 48 Mechanical thrombectomy Ideal If
M1 MCA Occlusion Carotid Occlusion
SLIDE 49 NCCT/CTA now standard of care and should be performed sequentially while on CT table
49
SLIDE 50
“Neurons over nephrons” in major stroke
SLIDE 51
“CIN” called into question
SLIDE 52
Primary Stroke Centre Model with Telestroke
SLIDE 53 The How To?
- EMS transport to right hospital
- Primary Stroke Centres
- CT/CTA 24/7
- Telestroke capability to hub CSC
- DTN<30 min
- DIDO <45 min
SLIDE 54
SLIDE 55 Target: Stroke Best Practice Strategies
- 1. *EMS Pre-Notification
- 2. Stroke Toolkit
- 3. Rapid Triage and
Stroke Team Notification
- 4. *Single Call Activation
System
- 5. *Transfer Directly to CT
- 6. Rapid Brain Imaging
- 7. *POC Laboratory
Testing
- 8. *Premix TPA
- 9. *Rapid TPA Access -
store TPA in ED/radiology, start in imaging suite 10.Team approach 11.*Prompt data feedback
SLIDE 56 STAT! STROKE Prehospital Notification
Stroke neurologist Triage nurse ED physician CT tech Patient care attendant ED bedside nurse Angio team Neuro-IR
SLIDE 57 Phase 2
Phase 1 Phase 2 Phase 3
NCCT CTA
Keep on the CT table for immediate CTA!
NCCT prep/scanning time <5 min
CTA
NCCT to tPA decision via telestroke <10 min mix/prep for bolus <5 min Door to CT scanner <10 min CTA prep/scanning time <5 min CTA reformatting time <5 min All images to decision <10 min
DTN <30 min/ DIDO <45 min
Decision to door out <10 min
Keep on EMS stretcher!
Door in door out <45 minutes Door to needle <30 minutes
57
SLIDE 58 LSN Time EMS Activation First door in CT/CTA IV tPA start time First Door Out Second door in Repeat CT/CTA Groin Puncture
Revasculariz
Second door
Home time % in first 90 days
FUTURE
58
SLIDE 59 The How To?
- EMS transport to right hospital
- Primary Stroke Centres
- CT/CTA 24/7
- Telestroke capability to hub CSC
- DTN<30 min
- DIDO <45 min
- Comprehensive Stroke Centre
- Bypass of PSCs if severe+by distance
SLIDE 60 Onset to Substantial Reperfusion and Disability Outcomes (mRS) at 3 Months
2016-03-21 HERMES Collaboration 60
SLIDE 62 Transport decisions evolving
angio EVT
SLIDE 63 Transport decisions evolving
angio EVT
SLIDE 64 Transport decisions evolving
angio EVT
SLIDE 65 What to do when more than one stroke centre in metro area?
PSC CSC PSC PSC
SLIDE 66 Golden 2 Hours of Stroke
2016-03-21 HERMES Collaboration 66
P=0.001
66.9% 8.3%
SLIDE 67 2016-03-21 HERMES Collaboration 67
207 65 15 21 29 50 31 32 47 42 Transfer Direct admit
Workflow Times in Direct and Transfer Patients
(minutes, medians) Onset to ED ED to imaging start Imaging to randomization Randomization to puncture Puncture to reperfusion
SLIDE 68 Baseline Characteristics Differed by Time Window of Randomization
30-120 mins 121-240 mins 241-360 mins >360 mins N 194 657 352 79 Age 68.7 66.5 65.8 64.5 Sex (female) 53.1% 46.0% 44.7% 53.2% NIHSS 17.2 17.0 16.5 16.1 Direct (vs transfer) 97.9% 75.5% 37.8% 66.7% IV tPA 85.6% 89.0% 86.9% 45.6% Location ICA 32.1% 21.8% 16.2% 21.8% M1 62.2% 70.2% 76.2% 71.8% ASPECTS 9.0 8.4 7.8 8.0 2016-03-21 HERMES Collaboration 68
SLIDE 69
SLIDE 70
SLIDE 71
SLIDE 72 72
Alberta Acute Stroke Treatment 2016
Comprehensive Stroke Centre Primary Stroke Centre
SLIDE 73 3 way onscene communication for rural areas
- LAMSS >4 + <6h/wakeups
- EMS provider at scene
- Comprehensive stroke centre team
- Transport physician
SLIDE 74 The Conversation at Scene
Truly Hemiplegic? Helicopter available? Weather? Transport times to PSC vs CSC? Last seen normal? tPA ineligible? Clinically worsening? ICH? Premorbid status? Should ambulance rendezvous with helicopter? PSC operational?
DECISION! GO!
SLIDE 75 Optimize NCCT mCTA with thick MIPs Pr
CTA 23 mm Thick MIPs
1223h
mCTA CTA neck/head Thin section NCCT Quality NCCT
SLIDE 76 mCTA with thick MIPs Protocol
1223h
SLIDE 77 Fast DTNs translate to fast DTGP times
Median DtoGP: 60 66 60 62 47 25th% DtoGP: 44 42 46 35 30
SLIDE 78
Thank-you for your attention!